Myomo Inc (MYO)
3.90
+0.19
(+5.12%)
USD |
NYAM |
Sep 27, 16:00
3.87
-0.03
(-0.77%)
After-Hours: 20:00
Myomo SG&A Expense (Annual): 18.78M for Dec. 31, 2023
SG&A Expense (Annual) Chart
Historical SG&A Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 18.78M |
| December 31, 2022 | 18.44M |
| December 31, 2021 | 18.02M |
| December 31, 2020 | 13.82M |
| Date | Value |
|---|---|
| December 31, 2019 | 11.46M |
| December 31, 2018 | 10.41M |
| December 31, 2017 | 5.85M |
| December 31, 2016 | 2.975M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Annual) Range, Past 5 Years
11.46M
Minimum
2019
18.78M
Maximum
2023
16.10M
Average
18.02M
Median
2021
SG&A Expense (Annual) Benchmarks
| Nevro Corp | 334.70M |
| Cutera Inc | 176.32M |
| IRIDEX Corp | 24.98M |
| Stereotaxis Inc | 26.43M |
| Electromed Inc | 34.49M |